The Kuwaiti healthcare system is characterized by high levels of expenditure and investment, driven by the country’s Vision 2035 strategic development plan. In 2024, Kuwait spent 5.1% of its GDP on healthcare, ranking second highest in the Gulf Cooperation Council (GCC) and third among GCC countries in health spending per capita in US dollar terms, following Qatar and the UAE. The healthcare expenditure in Kuwait is projected to grow steadily at a promising compound annual growth rate (CAGR) of 4.2% over the next four years.

The healthcare system in Kuwait is primarily owned and operated by the government through the Ministry of Health (MoH) and the Kuwait Food and Drug Administration (FDA). It is divided between the public and private sectors, with the public sector currently playing a dominant role, catering to roughly 80% of the country’s healthcare needs. Kuwait operates as a welfare state where Kuwaitis and expatriates are covered by a universal health scheme, with more extensive coverage for nationals. Kuwaiti citizens have free access to healthcare services, including coverage for treating life threatening conditions. This encompasses treatment in Kuwait or designated GCC and European countries with advanced healthcare capabilities.